Study of Opioid Rotation Versus Opioid Escalation in Patients With Moderate to Severe Cancer Pain
NCT02084355 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 136
Last updated 2014-03-12
Summary
Although opioid rotation is well known treatment modality in reducing pain and opioid-induced neurotoxicity, it is not established whether opioid rotation is more appropriate or opioid escalation is more effective in controlling significant pain in cancer patients under opioid medication.
\- The purpose of this study is to determine effective therapy out of opioid rotation and opioid dose escalation in patients with moderate to severe cancer pain who have been already treated with strong opioid.
Conditions
Interventions
- DRUG
-
oral oxycodone
- DRUG
-
oral hydromorphone
- DRUG
-
fentanyl patch
Sponsors & Collaborators
-
Gyeongsang National University Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-04-30
- Primary Completion
- 2015-12-31
- Completion
- 2016-01-31
Countries
- South Korea
Study Locations
More Related Trials
-
To Demonstrate Equivalence in Analgesic Efficacy & Bowel Function Between OXN PR Higher Dose & Lower Dose Tablet Strengths in Subjects With Non-cancer or Cancer Pain
NCT02321397 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Opioid Misuse in Patients with Cancer
NCT06489769 ·Status: RECRUITING
-
Efficacy and Safety of Fentanyl ETHYPHARM for Breakthrough Pain in Opioid-treated Patients With Cancer
NCT01842893 ·Status: COMPLETED ·Phase: PHASE3
-
IV PCA With or Without Continuous Dose vs Oral Opioid to Maintain Analgesia for Severe Cancer Pain After Successful Titration
NCT04785768 ·Status: COMPLETED ·Phase: PHASE3
-
Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer
NCT00726830 ·Status: TERMINATED ·Phase: NA
-
Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain
NCT00666211 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Opioid Infusion Rate on Abuse Liability Potential of Intravenous Hydromorphone for Cancer Pain
NCT04296305 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Fentanyl Matrix Application for Cancer Pain: Multicenter, Prospective, Observational Study
NCT01816503 ·Status: COMPLETED
-
An Efficacy and Safety Study of Oral Osmotic Therapeutic System (OROS) Hydromorphone Hydrochloride (HCl) in Participants With Cancer Related Pain
NCT01205126 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate Effectiveness and Tolerability of OROS Hydromorphone for Cancer Pain Treatment in Korean Patients
NCT01621100 ·Status: COMPLETED ·Phase: PHASE4
-
Oxymorphone Extended Release in Patients With Cancer or Neuropathic Pain
NCT00911261 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate the Efficacy and Safety of ACTIQ in Patients With Cancer and Breakthrough Pain
NCT00236145 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study of KW-2246 in Patients With Cancer Pain
NCT00355628 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Efficacy and Safety of Oxycodone/Naloxone Compared to OxyContin in Korean Cancer Patients
NCT01313780 ·Status: COMPLETED ·Phase: PHASE4
-
An Efficacy and Safety Study of Hydromorphone Hydrochloride (HCl) Oral Osmotic System (OROS) in the Reduction of Breakthrough Pain Medication Frequency in Participants With Cancer
NCT01006356 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Usefulness and Quality of Life of OROS Hydromorphone in Patients Who Have Not Been Treated With a Strong Opioid
NCT01532895 ·Status: COMPLETED
-
Long-term Safety Study of Sublingual Fentanyl Tablets in Cancer Patients
NCT00263575 ·Status: COMPLETED ·Phase: PHASE3
-
Opioid Titration in the Hospice Setting: Barriers Assessment and Modification of the Model Order Sheet and Protocol
NCT01230515 ·Status: COMPLETED
-
An Observational Study to Investigate Clinical Usefulness of OROS Hydromorphone in Korean Cancer Patients
NCT01273454 ·Status: COMPLETED
-
A Study Comparing Oxycodone to Oxycodone/Naloxone in Moderate to Severe, Chronic Cancer Pain
NCT00513656 ·Status: COMPLETED ·Phase: PHASE2
-
An Efficacy and Safety Study of Fentanyl (JNS020QD) in Participants With Cancer Pain
NCT00641667 ·Status: COMPLETED ·Phase: PHASE3
-
Optimizing Subcutaneous FEntanyl titRation: RApid Achievement of Adequate Exposure When Treating Cancer-Related paIn.
NCT06498037 ·Status: RECRUITING ·Phase: PHASE4
-
A Study to Evaluate the Safety and Effectiveness of Fentanyl-TTS Compared to Weak Opioids in Patients With Moderate to Severe Chronic Cancer Pain Previously Treated With NSAIDS (Non-steroidal Anti-inflammatory Drugs).
NCT00576017 ·Status: COMPLETED ·Phase: PHASE4
-
Morphine Versus Methadone As First Line Strong Opioid for Cancer Pain
NCT00634010 ·Status: TERMINATED ·Phase: PHASE3
-
A Comparison of the Perception of a Needle Injection Pain Between Cancer Patients Receiving Opioid Therapy Versus Opioid-naive Patients
NCT01704469 ·Status: COMPLETED ·Phase: NA